JSK Therapeutics - Crunchbase Company Profile & Funding

Q: Where is JSK Therapeutics's headquarters?

JSK Therapeutics is located in Sandy, Utah, United States.

Q: When was the last funding round for JSK Therapeutics?

JSK Therapeutics closed its last funding round on obfuscated from a Seed round.

Q: How much funding has JSK Therapeutics raised to date?

JSK Therapeutics has raised obfuscated.

Overview

JSK Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About JSK Therapeutics

CB Rank

103999

JSK Therapeutics develops new anti-cancer therapeutics.

Founded

obfuscation

Private

Seed

Sandy, Utah, United States

11-50

www.jskthera.com/

Biotechnology

Pharmaceutical

Therapeutics

Funding Rounds

Seed

OBF

obfuscation

Key People

Thomas P. Kennedy: Co-Founder
Venkata Yellepeddi: Chief Science Officer

Details

Operating Status

Active

Company Type

For Profit

Founders

Rosa Chasity, Thomas P. Kennedy

About the Company

JSK Therapeutics provides developments for the treatment of many cancers. By employing chemistry to fight cancer, they are helping to reduce pain and suffering. Their goal is to make cancer sufferers' lives better.

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

JS-K Molecule

A nitric oxide donor prodrug designed to release nitric oxide selectively in cancer cells to inhibit tumor growth and metastasis.

JS-K for COVID-19 Treatment

A nitric oxide donor compound proposed for systemic administration to reduce inflammation and organ failure in COVID-19 patients.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - JSK Therapeutics	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - JSK Therapeutics	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - JSK Therapeutics	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - JSK Therapeutics	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - JSK Therapeutics	—	obfuscated obfuscation	—	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - JSK Therapeutics	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - JSK Therapeutics	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - JSK Therapeutics	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - JSK Therapeutics	—	obfuscated obfuscation	—	Seed
obfuscated obfuscation	Seed Round - JSK Therapeutics	—	obfuscated obfuscation	—	Seed